U.S. FDA issues VAI classification to Natco Pharma’s FDF unit in Vizag

VAI is one of the three classifications, the U.S. FDA issues implying objectionable conditions or practices were found, during the inspection, but the regulator is not prepared to take or recommend…
More news in Industry
Higher apparel prices fail to lift festive sales; industry pins hopes on wedding season
Pricol looks at doubling revenue post demerger
Infra push and low base effect pushes core sector growth to series-high of 10.9% in October 2026